Archive - November 2020
£12.2m boost for coronavirus genomic surveillance
J&J launches second PhIII COVID-19 trial
Six new medicines leap towards EU approval
Talk Therapy Patients: How Secure Are Your Sessions?
Red Eyes? Their Owner Could Use Dirty Needles
Synairgen’s SNG001 advances into phase 3 COVID-19 trial
Pandemic Naysayers Sneak into Hospital to See if ICU Is Full
Sobi’s Gamifant receives final rejection from CHMP for primary HLH